Pelthos Therapeutics (PTHS) Net Shares Issued and Repurchased (2023 - 2025)

Pelthos Therapeutics has reported Net Shares Issued and Repurchased for 3 years, with the latest figure at $7899.0 in Q2 2025.

• On a quarterly basis, Net Shares Issued and Repurchased fell 87.54% year-over-year to $7899.0 in Q2 2025; TTM through Jun 2025 was $7899.0, a 87.54% decrease from a year earlier, with the FY2024 full-year figure at $684000.0, up 331.08% from the prior year.
• Net Shares Issued and Repurchased was $7899.0 for Q2 2025 at Pelthos Therapeutics, down from $684000.0 in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $684000.0 in Q4 2024, with the low at $7899.0 in Q2 2025.
• Average Net Shares Issued and Repurchased over 3 years is $228492.2, with a median of $111035.0 recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased surged 331.08% in 2024, then plunged 87.54% in 2025.
• Over 3 years, Net Shares Issued and Repurchased stood at $158670.0 in 2023, then soared by 331.08% to $684000.0 in 2024, then sank by 98.85% to $7899.0 in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $7899.0 (Q2 2025), $684000.0 (Q4 2024), and $63400.0 (Q2 2024), per Business Quant data.